Sign in

Paul K. Sue, MDCM FIDSA, FPIDS

@paulksue1.bsky.social
1K followers 788 following 15 posts

Director, Pediatric Transplant & Immunocompromised Host (PITCH) ID Service Columbia University Medical Center New York, NY. Views my own.

PostsRepliesMedia
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 21/10/2025
👍 Twice daily Chlorhexidine self care reduces asymptomatic bacteriuria by 56% following #KT > great discussion by #HannahNam on the #PROTEKT study #IDWEEK2025
040
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 21/10/2025
👍 Fantastic study by #WilliamCappucio on #Short-Course (<10D)duration of antibiotics as non-inferior to prolonged (>10 d) antibiotics in uncomplicated gram negative bacteremia among Adult #SOT. #IDWEEK2025
110
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
TransplantID.Net - American Society of Transplantation @transplantidnet.bsky.social · 20/10/2025
Counseling immunocompromised patients on minimizing 🆔 risks? Don't reinvent the 🛞! @astinfo.bsky.social @ast-idcop.bsky.social has Power2Save Safer Living Patient Information sheets! Translations and more topics in upcoming years! transplantid.net?patient_educ...
043
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 20/10/2025
Highway to the donor danger zone? Please join the #TxID crew Tues 8am in B312 for 'Should I Take This Donor?' 🤔 w donor-derived infx experts Stephanie Pouch and Emily Blumberg dropping knowledge on all your donor-related q's ♥️ 🫁 🫘 @aneeshkmehta.bsky.social #IDSky @idweek.bsky.social #IDWeek2025
052
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 20/10/2025
📣 The #IDSA #IHCoP will be hosting the #IHCoP #TxID Networking Reception tomorrow at 5PM at the #OmniAtlantaHotel (M4 Grand Ballroom D) followed by a 👍 curated #PosterWalk. Click here 👇 to register www.surveymonkey.com/r/IHCoP2025 (or just show up!) #AllWelcome #IDWEEK2015
000
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 20/10/2025
🥳 A huge crowd gathered at the #IHCoP #BugHub stage to listen to #AlpanaWaghmere, #StellaRadosta & #GabrielMotoa discuss #ChallengingCases in #TxID!! #IDWEEK2025
061
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 19/10/2025
Thanks as always for these very helpful links! Great resource for both fellows and current practitioners in #TID #TxID #IDSky
011
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 20/10/2025
👍 Excellent session this morning at the #BugHub by #JeremyWalker hosted by @AndreaRuff and @EmilyEichenberger on #BridigingTheGap between General & #TxID! #IHCOP #IDWEEK2025
030
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Joanna Schaenman, MD, PhD @jschaenmanmd.bsky.social · 20/10/2025
Packed house difficult mold infections - very hard to say definitively if combination therapy is useful for Mucor per Dimitrios Farmakiotis , recommended to avoid use outside of stepdown therapy etc, #IDWeek2025 @idweek.bsky.social #TxID @sarahhammond.bsky.social
162
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 19/10/2025
🥳 Awesome 2 catch up w/ #HopkinsFam @tcrowellmd.bsky.social & #AmitaGupta at #BigBash @#IDWEEK2025!!
031
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
UW Infectious Disease Fellowship Program @uwidfellowship.bsky.social · 19/10/2025
Prolonged applause for Dr Demetri Daskalakis, formerly of the CDC, winner of the HIV Medical Association Transformative Leader Award… #IDSky #IDWeek #IDStrong
211631
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
PIDS @pidsociety.bsky.social · 19/10/2025
Walter Orenstein, MD, FPIDS, an influential figure in public health and immunization efforts, including policy and hesitancy, is the Pediatric Infectious Diseases Society (PIDS) 2025 Walter T. Hughes Distinguished Physician Award honoree. pids.org/2025/10/19/p...
Blue slide announcing PIDS Award winner, Walter Orenstein, MD, FPIDSDr. Orenstein stands at the IDWeek lectern delivering acceptance remarks
191
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 19/10/2025
🙌 Congratulations to #CindySears for her receipt of the #FlemingLifetime Achievement award @ #IDWEEK2025! An amazing legacy and absolutely inspiring!! #IDWEEK2025
091
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 19/10/2025
#IDWEEK is Underway!! >> #JavierMunoz kicking off #IDWEEK with selections from #Hamilton, and a call for the ID community to continue it's mission to use science to impact the world 🌎 #IDWEEK2025 #WeAreID
060
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Megan Ranney MD MPH @meganranney.bsky.social · 01/12/2024
A friend sent this article to me today. It feels like a good moment to remind us: the LLM outperformed physicians on STRUCTURED cases. Someday the AIs may perform better than us in the unstructured, messy, real-world patient encounter...but that day is not today.🩺🛟 jamanetwork.com/journals/jam...
jamanetwork.com
Large Language Model Influence on Diagnostic Reasoning
This randomized clinical trial evaluates the diagnostic performance of physicians with use of a large language model compared with conventional resources.
1514936
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Ricardo M. La Hoz @ricardolahozmd.bsky.social · 23/11/2024
This is a nice and informative prospective study of donor-derived Mycoplasma and Ureaplasmain lung transplant recipients from our Duke Colleagues. Nicely done Patrick Tam! #TxID #IDSky www.amjtransplant.org/article/S160...
amjtransplant.org
Donor-derived Mycoplasma and Ureaplasma infections in lung transplant recipients: A prospective study of donor and recipient respiratory tract screening and recipient outcomes
Mycoplasma hominis and Ureaplasma species are urogenital mollicutes that can cause serious donor-derived infections in lung transplant recipients. Best practices for mollicute screening remain unknown...
13010
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 20/11/2024
🔥BALANCE RCT🔥 74 hospitals in 7 countries 3,608 patients A 7-day course of antibiotics for hospitalized patients with bloodstream infections was non inferior to 14d within a 4% prespecified margin for mortality at 90 days #idsky www.nejm.org/doi/full/10....
nejm.org
Antibiotic Treatment for 7 versus 14 Days in Patients with Bloodstream Infections | NEJM
Bloodstream infections are associated with substantial morbidity and mortality. Early, appropriate antibiotic therapy is important, but the duration of treatment is uncertain. In a multicenter, non...
107429
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 21/11/2024
💉 For my #PedsTID friends >> wondering if folks are advocating multiple doses of the 2024-2025 COVID19 booster for your previously fully 💉 #Immunocompromised 👶? If so, how many more? 🙏 www.cdc.gov/mmwr/volumes...
cdc.gov
Use of 2024-2025 COVID-19 Vaccines ...
This report describes the Advisory Committee on Immunization Practices’ recommendations for the 2024-25 COVID-19 vaccines.
130
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 18/11/2024
🆕️🔥Treatment of Invasive Pulmonary Aspergillosis and Preventive and Empirical Therapy for Invasive Candidiasis in Adult Pulmonary and Critical Care Patients. An Official American Thoracic Society Clinical Practice Guideline #idsky www.atsjournals.org/doi/abs/10.1...
4176
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Transplant Infectious Disease Journal @thetxidjournal.bsky.social · 17/11/2024
Got a cool #TxID case? Let @maricarmalinis.bsky.social know! See below for more details.
0137
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 18/11/2024
👍Fantastic study 👀 at whether #shorterisbetter in Neutropenic Bacteremia in adults. >80% GNB with almost 18% MDRO, profound neutropenia in 83% of enrollees & post therapy Abx PPX in 65%. Adequate source control in 70%-100%. No diff in relapse or ☠️ if <10 vs > 10 ABX days. #IDSky #TIDSky
1163
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Michael G. Ison, MD MS @michaelisonmd.bsky.social · 18/11/2024
Want to learn about the treatment of RVI in immunocompromised patients? Join us for the next @ESCMID.bsky.social ESGICH/ESGREV webinar on the treatment of RVI. Chairs: Hans Hirsch and @michaelisonmd.bsky.social Talks by: Pauline Vetter, Jose Luise Pinana, Fareed Khawaja
23413
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Paul Sax @paulsaxmd.bsky.social · 18/11/2024
Excellent analysis of what happens when a clinical trial is under powered. In this example, it's the use of air purifiers in nursing homes and preventing respiratory tract infections. Results suggest it might work. Or it might not. @apsmunro.bsky.social open.substack.com/pub/alasdair...
open.substack.com
How to not be completely wrong about air filters
A new RCT of HEPA filters for residential care homes gets heads spinning
3274
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 18/11/2024
💩 Ugh -- ".. only 12.1% of NDM-producing isolates were susceptible to cefiderocol using the 2024 EUCAST version 14.0 DD breakpoint. Ceftazidime/avibactam and aztreonam synergy was seen in 87.5% of isolates tested..." In some settings, empiric use in MBL -producing isolates may be inappropriate...
000
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Maricar Malinis @maricarmalinis.bsky.social · 16/11/2024
The @idsainfo.bsky.social IHCOP welcomes all who are involved in the care of immunocompromised hosts. We have a great opportunity to advance the field, build and sustain the TID workforce. Please sign Up 🤓 my.idsociety.org/volunteeropp...
my.idsociety.org
IDSA Immunocompromised Host Community of Practice
The purpose of the Immunocompromised Host Community of Practice (COP) is to create a community that
12711
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Hensley Lab @scottehensley.bsky.social · 16/11/2024
The preliminary sequence from the H5N1 human case in British Columbia has been posted and it is not good news. The virus potentially has a quasispecies at HA residue 226 (H3 numbering). This is bad news because we know that mutations at residue 226 can increase binding to human receptors. 1/
2022154953
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
BK. Titanji @boghuma.bsky.social · 16/11/2024
Health officials in California have confirmed the first case of mpox clade I in the US. Patient is a returning traveller's who traveled to eastern Africa. This is not unexpected because the world is interconnected and there are ongoing outbreaks of clade I mpox in Africa. apnews.com/article/mpox...
apnews.com
US health officials report 1st case of new form of mpox in a traveler
Health officials say they have confirmed the first U.S. case of a new form of mpox that was first seen in eastern Congo.
314042
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
David Griffin 🦠🧫💉 @drdavidwjg.bsky.social · 16/11/2024
Great point! We often advocate for a unifying diagnosis (Occam’s razor), but in people with immunocompromise, it’s important not to disregard Hickam’s dictum; “Patients can have as many diseases as they damn well please!” #Medsky #IDSky #TxIDSky
3161
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Ilan Schwartz @germhuntermd.bsky.social · 15/11/2024
All pediatricians and infectious diseases doctors right now #PedsSky #IDSky #MedSky
pommel horse guy from us olympics mens gymnastics team resting with his eyes closed before his turn to compete at the olympics
411244155
Reposted by Paul K. Sue, MDCM FIDSA, FPIDS
Helen Branswell 🇨🇦 @helenbranswell.bsky.social · 15/11/2024
The US confirmed #H5N1 #birdflu count is now 52, from 7 states. 58% due to exposure to infected cows, 40% to infected poultry. The mystery Missouri case rounds out the mix. To date all cases have been mild. www.cdc.gov/bird-flu/sit...
912347
Paul K. Sue, MDCM FIDSA, FPIDS @paulksue1.bsky.social · 15/11/2024
🤔Hmm...new here. Anyone else around? How is the neighborhood? #PedsTID #WeAreID #TransplantID #IDSA #JPIDS #ASTIDCOP #ASTCT #IPTA
media.tenor.com
a white cat is laying on its back with the words hello there in the background
ALT: a white cat is laying on its back with the words hello there in the background
160